Blair says collaboration on Covid could have cut three months off crisis

Former prime minister tells the Guardian the world must be better prepared for the next pandemic

World leaders could have cut the length of the Covid outbreak by three months if they had collaborated on vaccines, testing and drugs, Tony Blair has claimed as he launched a report on preparing for the next deadly pandemic.

The former Labour prime minister urged the UK to take the lead in developing a new “health security infrastructure” that would ensure countries coordinate better in identifying emerging new threats as well as developing, testing and manufacturing vaccines and treatments.

“Had there been global coordination a year ago, I think we could have shaved at least three months off this virus,” Blair told the Guardian in an interview.

The report, The New Necessary, published by his Institute for Global Change, argues that in future, with the right international coordination and investment, the creation of a new vaccine could be achieved in as little as 100 days.

“The time that it’s taken for us to identify the virus, to develop a vaccine and to get it into production and distribution has been roughly, 15 months. And the result of that has been that the world has suffered a huge, catastrophic economic event as well as a health event,” he said.

“The obvious lesson to draw for the future is, number one, you have to prepare for the potential of this happening again, or with different variants of this particular virus. And number two, you cannot afford to take this long to get on top of it.”

With Boris Johnson chairing the G7, Blair called on the UK to spearhead the creation of a more responsive system for tracking diseases and collaborating on tackling them.

The report calls on the government to treat preparing for the next pandemic as “akin to a military operation”, tracking the emergence of new diseases using state-of-the-art surveillance and having “surge capacity” ready to produce vaccines and drugs.

It calls for pandemics to be dealt with as potential security threats – like climate change or cyber-attacks, Blair says – to ensure the issue gets the government time and attention it requires.

Johnson was criticised for skipping several Cobra meetings in the early days of the pandemic, leaving them to be chaired by the health secretary, Matt Hancock.

Perhaps ironically, for someone regarded by his critics as an arch free marketeer, Blair argues that in tackling the virus over the past year, “there was a whole series of things left to the market which it was never sensible to leave to the market”.

As an example, he points the bioreactors needed to produce vaccines. “A lot of the companies that were developing the vaccines didn’t have large bioreactor capacity, whereas a lot of the bioreactor capacity was in other large pharmaceutical companies who weren’t doing the vaccines. Now, in a rational world you would have been repurposing some of that bioreactor capacity to accelerate the production of vaccine. I don’t think that was even the discussion that took place at an international level.”

Blair’s institute is part thinktank, part consultancy, advising global leaders on how to make use of emerging technologies.

He has made a series of high-profile interventions during the crisis, advocating some measures that have subsequently been adopted by the UK government, including mass testing and more recently vaccine passports.

Having previously denied it was considering the idea, the government this week announced a review of the idea of “Covid status certificates” that would allow people to demonstrate they have been vaccinated or had a recent negative test result.

Blair, who faced a political revolt when he tried to introduce a nationwide system of ID cards as prime minister, argues that some kind of certification system is inevitable, so the government should take control of it rather than allow it to develop ad hoc.

“What is obvious is that if people are going to be in close proximity with others, they’ll probably prefer to know their Covid status – either test or vaccine,” he said. “Then the only question is, do you just let the system grow up topsy-turvy, with people doing their own thing, and making their own rules and regulations around it, or to try and systematise it. And I just think it’s inevitable that you will move to the second,” he said.

He brushed off claims that some groups – those without access to technology, for example – would be disadvantaged. “There’s a big problem with the inequality between different people with digital connection, but you deal with that by dealing with the problem.”

In response to the idea that such certificates – likely to be held on people’s mobile phones – would create privacy issues like those that helped to sink his ID cards plan, he said: “You know, my personal view is that this resistance was always exaggerated. It was loud, but not actually that broad. I used to say to people, you know, your average supermarket’s got more information on you than the government’s got.”

Contributor

Heather Stewart

The GuardianTramp

Related Content

Article image
How are Covid vaccines produced and why have there been delays?
The newness of some of the technology and gaps in global preparedness have led to bottlenecks

Peter Beaumont

19, Mar, 2021 @12:03 PM

Article image
Will Novavax and Johnson & Johnson Covid vaccines work against variants?
Everything you need to know about the trial results for the two new coronavirus vaccines

Archie Bland and Nicola Davis

29, Jan, 2021 @7:05 PM

Article image
Under-30s may have ‘small delay’ in getting Covid jab, says Jonathan Van-Tam
England’s deputy chief medical officer says delay would be precaution against rare side-effect of blood clots

Aubrey Allegretti Political correspondent

07, Apr, 2021 @6:24 PM

Article image
AstraZeneca says vaccine against new Covid variants may take six months
Anglo-Swedish pharmaceutical firm’s profits rise to $7.4bn as main business ‘remains strong’

Jasper Jolly and Nicola Davis

11, Feb, 2021 @8:42 AM

Article image
More data needed before giving just one vaccine dose, says Covid adviser
Tony Blair and others make argument for giving more people a single jab rather than two

Kevin Rawlinson

23, Dec, 2020 @5:39 PM

Article image
Analysis: is it wise for England to mix and match Covid vaccines?
US experts warn against plan to give different second jab if supplies run low

Sarah Boseley Health editor

03, Jan, 2021 @5:39 PM

Article image
Pfizer/BioNTech vaccine announcement is cause for cautious celebration
Interim trial results are encouraging as scientists welcome news

Sarah Boseley

09, Nov, 2020 @5:56 PM

Article image
Vaccine clinical trials for Covid variants to start in summer, MPs told
Updated versions of vaccine are being developed in case variants evade immunity provided by current shots

Ian Sample Science editor

24, Feb, 2021 @3:55 PM

Article image
A series of knocks: Oxford/AstraZeneca's bumpy road to Covid vaccine confidence
From doubts about efficacy in older people to questions about variants, scientists have faced a battle to convince the public and regulators

Sarah Boseley Health editor

09, Feb, 2021 @2:47 PM

Article image
Number of UK Covid vaccinations falls by a third as vaccine supply dips
Factors at play include high uptake plus stockpiling for second doses, but Matt Hancock promises ‘bumper weeks in March’

Dan Sabbagh and Natalie Grover

23, Feb, 2021 @7:57 PM